Submit Manuscript    >>    Login | Register

AF Literature Database


Search Knowledgebase by



Author last name starts with
B. Weijs(4)Ayman A. Hussein, MD(3)Asirvatham Samuel J SJ(3)
Alan S. Go, MD(3)Charlotte Eitel, MD(3)Botto GL(2)
Casella M(2)Bokeriia L A LA(2)Antonio Hernández-Madrid(2)
Christian Sohns(2)Bengt Zöller(2)Badger Troy J TJ(2)
Charlotte Eitel(2)Blanke Philipp P(2)Anné Wim W(2)
Chamberlain AM(2)Berenfeld Omer O(2)Caputo M(2)
Chao TF(2)Chen Peng-Sheng PS(2)Andrade JG(2)
Akira Fukui, MD(2)Albert Nancy M NM(2)Ajay K Jain(2)
Cook G Elliott GE(2)Aboulhosn Jamil J(1)Cambronero Francisco F(1)
Amini Reza R(1)Christoph Ohlmeier(1)Akhtar Raja Parvez RP(1)
Baba Osamu O(1)Borleffs C Jan Willem CJ(1)Ahlsson Anders A(1)
Caldwell Jane Cochrane JC(1)Cairns JA(1)Alf Inge Larsen(1)
Choi Andrew D AD(1)Boveda S S(1)Aslanidi Oleg V OV(1)
Chimenti Cristina C(1)Beaulieu Yanick Y(1)Biondi Bernadette B(1)
Bart Maesen(1)Courtney M. Campbell, PhD(1)Budzyński Jacek J(1)
Acosta Stefan S(1)Albert Alexander A(1)Cannon Christopher P CP(1)
Acar Gürkan G(1)Brevoord D(1)


Literature Related to Frison L [Author]
1
  • Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation


    Authors : Lip GY; Frison L; Halperin JL;

    Affiliations : correspondence: Prof. Gregory Y. H. Lip, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham B18 7QH, England (Email: g.y.h.lip@bham.ac.uk).

    Journal : Journal of the American College of Cardiology   (2010)

    Related Links: Pubmed | Publisher website


  • Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation


    Authors : Lip GY; Frison L; Halperin JL;

    Affiliations : * Reprint requests and correspondence: Prof. Gregory Y. H. Lip, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham B18 7QH, England (Email: g.y.h.lip@bham.ac.uk).

    Journal : Journal of American College of Cardiology   (2010)

    Related Links: Pubmed | Publisher website


  • Pharmacological cardioversion of atrial fibrillation—a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously


    Authors : Rónaszéki A; Alings M; Egstrup K; Gaciong Z; Hranai M; Király C; Sereg M; Figatowski W; Bondarov P; Johansson S; Frison L; Edvardsson N;

    Affiliations : Department of Cardiology, Péterfy Hospital, Budapest, Hungary. Tel: +46 31 776 1000; fax: +46 31 776 3737 Email: anders.r.berggren@astrazeneca.com

    Journal : Eurpopace   (2011)

    Related Links: Pubmed | Publisher website


  • Pharmacological cardioversion of atrial fibrillation—a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously


    Authors : Rónaszéki A; Alings M; Egstrup K; Gaciong Z; Hranai M; Király C; Sereg M; Figatowski W; Bondarov P; Johansson S; Frison L; Edvardsson N;

    Affiliations : Department of Cardiology, Péterfy Hospital, Budapest, Hungary. Corresponding author. Tel: +46 31 776 1000; fax: +46 31 776 3737, Email: anders.r.berggren@astrazeneca.com

    Journal : EP Europace   (2011)

    Related Links: Pubmed | Publisher website


Biosense Webster
event date
Introduction to AFib
Ablation Specialist

View Ablation Specialists